INDV (Indivior PLC) Expected net earnings per share growth this year

Official company branding of indivior.com (INDV)

Indivior PLC dominates opioid addiction therapy due to its unique clinical expertise and high barriers to entry. The annual percentage growth in net income per share clearly demonstrates the profitability trend, while the 23.10 metric confirms the current level. Production has been outsourced to external partners under strict GMP control. Patent protection for Sublocade and government support provide Indivior PLC with significant pricing power.

INDV - Indivior Corp Earnings growth in current year over the range 02/21/2024 - 11/12/2026

Comprehensive metric breakdowns and analytics for Indivior PLC (INDV)

- price and consensus price forecast:
Stock Quotes Indivior plc|INDV - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Indivior Corp|INDV - Total Company Value
- shareholders' equity book value data:
Equity per Share Indivior|INDV - Book Capitalization|Capitalization to Book Value Ratio indivior.com|INDV - Company Total Assets
- debt and liquidity details:
Total Debt to Capital Coefficient Indivior PLC|INDV - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity indivior.com|INDV - Company Aggregate Debts|Debts to Net Assets Indivior Corp|INDV - Company Long-Term Debt|Short-Term Debt Indivior|Intermediate Coverage Ratio indivior.com
- earnings and market ratios statistics:
INDV - Net Income|Expected Net Income Indivior PLC|INDV - Price to Earnings Ratio|Price to Expected Earnings Ratio Indivior Corp|INDV - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Indivior Corp|INDV - Operating profit EBITDA|Net earnings per share for the last 12 months Indivior|INDV - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months indivior.com|INDV - Earnings per share growth in current year|Projected earnings per share growth rate for next year Indivior PLC
Fundamental valuation:INDV - Indivior plc
Mass-produced product of indivior.com

This indicator measures the year-over-year dynamics of earnings per share, identifying whether growth is driven by real margin expansion or the artificial impact of share buybacks. By analyzing the annual trajectory of earnings per share, an investor can assess the sustainability of Indivior PLC (INDV), where stable demand for addiction treatments should offset legal risks and generic pressure.

Main competitors

Net earnings per share growth this year Collegium Pharma|CRON (Cronos) - Earnings growth in current year|Canopy Growth Corp. (CGC) - Expected net earnings per share growth this year|Earnings per share growth in current year High Tide Inc. (HITI)|auroramj.com - Earnings per share growth this year|Earnings growth in current year ACHV (Achieve Life Sciences, Inc.)|SKYE: Earnings per share growth this year|Anebulo - Earnings growth in current year|Expected net earnings per share growth this year InterCure Ltd. INCR|NTRB (nutriband.com) - Net earnings per share growth this year|NSRX (Nasus Pharma) - Earnings per share growth in current year|IGC (India Globalization Capital) - Earnings growth in current year|MIRA Pharma (MIRA) - Expected net earnings per share growth this year|Earnings per share growth in current year Flora Growth Corporation (FLGC)|IMCC - Earnings per share growth rate in current year|Earnings per share growth in current year Adial Pharmaceuticals, Inc. ADIL|Earnings per share increase in current year ARTL|ENSC: Net earnings per share growth this year|Earnings per share increase in current year TTNP (Titan Pharmaceuticals)|Greenlane Holdings Inc (GNLN) - Earnings per share growth in current year|Earnings per share trend in current year INM (InMed)|Earnings per share growth in current year Akanda|Earnings per share growth in current year ENVB|Earnings growth in current year BGXX|Net earnings per share growth this year Hempacco Co Inc. HPCO